-
1
-
-
0028022137
-
Leukemia: Management of relapse after allogeneic bone marrow transplantation
-
8040682 1:STN:280:DyaK2czhsFeqtw%3D%3D
-
Kumar L (1994) Leukemia: management of relapse after allogeneic bone marrow transplantation. J Clin Oncol 12:1710-1717
-
(1994)
J Clin Oncol
, vol.12
, pp. 1710-1717
-
-
Kumar, L.1
-
2
-
-
33845216261
-
Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine
-
16620971 10.1016/j.leukres.2006.03.003 1:CAS:528:DC%2BD28Xht12ksL7J
-
Graef T, Kuendgen A, Fenk R, Zohren F, Haas R, Kobbe G (2007) Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine. Leuk Res 31:257-259
-
(2007)
Leuk Res
, vol.31
, pp. 257-259
-
-
Graef, T.1
Kuendgen, A.2
Fenk, R.3
Zohren, F.4
Haas, R.5
Kobbe, G.6
-
3
-
-
65649120045
-
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia
-
19235255 10.1002/cncr.24198 1:CAS:528:DC%2BD1MXlt1ygu7o%3D
-
Jabbour E, Giralt S, Kantarjian H, Garcia-Manero G, Jagasia M, Kebriaei P et al (2009) Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia. Cancer 115(9):1899-1905
-
(2009)
Cancer
, vol.115
, Issue.9
, pp. 1899-1905
-
-
Jabbour, E.1
Giralt, S.2
Kantarjian, H.3
Garcia-Manero, G.4
Jagasia, M.5
Kebriaei, P.6
-
4
-
-
78649601394
-
Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: A dose and schedule finding study
-
20672358 10.1002/cncr.25500
-
de Lima M, Giralt S, Thall PF, de Padua Silva L, Jones RB, Komanduri K et al (2010) Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study. Cancer 116(23):5420-5431
-
(2010)
Cancer
, vol.116
, Issue.23
, pp. 5420-5431
-
-
De Lima, M.1
Giralt, S.2
Thall, P.F.3
De Padua Silva, L.4
Jones, R.B.5
Komanduri, K.6
-
5
-
-
77952419308
-
5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: A retrospective analysis
-
19820729 10.1038/bmt.2009.266 1:CAS:528:DC%2BC3cXlvVOnu7k%3D
-
Czibere A, Bruns I, Kroger N, Platzbecker U, Lind J, Zohren F et al (2010) 5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis. Bone Marrow Transplant 45(5):872-876
-
(2010)
Bone Marrow Transplant
, vol.45
, Issue.5
, pp. 872-876
-
-
Czibere, A.1
Bruns, I.2
Kroger, N.3
Platzbecker, U.4
Lind, J.5
Zohren, F.6
-
6
-
-
84857999119
-
Azacytidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: Results of the RELAZA trial
-
10.1038/leu.2011.234
-
Platzbecker U, Wermke M, Radke J, Oelsclaegel U, Seltmann F, Kiani A et al (2012) Azacytidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial. Leukemia 36:381-389
-
(2012)
Leukemia
, vol.36
, pp. 381-389
-
-
Platzbecker, U.1
Wermke, M.2
Radke, J.3
Oelsclaegel, U.4
Seltmann, F.5
Kiani, A.6
-
7
-
-
84864063679
-
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia
-
22689805 10.1200/JCO.2011.38.9429 1:CAS:528:DC%2BC38Xht1ygsr%2FI
-
Kantarjian HM, Thomas XG, Dmoszynska A, Wierzbowska A, Mazur G, Mayer J et al (2012) Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia. J Clin Oncol 30:2670-26778
-
(2012)
J Clin Oncol
, vol.30
, pp. 2670-26778
-
-
Kantarjian, H.M.1
Thomas, X.G.2
Dmoszynska, A.3
Wierzbowska, A.4
Mazur, G.5
Mayer, J.6
-
8
-
-
0034940793
-
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: Results of a phase i study
-
11548839 10.1038/sj.bmt.1703028 1:STN:280:DC%2BD3MvpvVyltg%3D%3D
-
Ravandi F, Kantarjian H, Cohen A, Davis M, O'Brien S, Anderlini P et al (2001) Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study. Bone Marrow Transplant 27:1221-1225
-
(2001)
Bone Marrow Transplant
, vol.27
, pp. 1221-1225
-
-
Ravandi, F.1
Kantarjian, H.2
Cohen, A.3
Davis, M.4
O'Brien, S.5
Anderlini, P.6
-
9
-
-
84555206702
-
Leukocytosis and circulating blasts in older adults with newly diagnosed acute myeloid leukemia: Are they valuable factors for therapeutic decision-making?
-
10.1016/j.clml.2011.06.003
-
Thomas X, Chelghoum Y, Cannas G, Elhamri M, Labussière H, Tigaud I et al (2011) Leukocytosis and circulating blasts in older adults with newly diagnosed acute myeloid leukemia: are they valuable factors for therapeutic decision-making? Clin Lymphoma Myeloma Leuk 4:342-9
-
(2011)
Clin Lymphoma Myeloma Leuk
, vol.4
, pp. 342-349
-
-
Thomas, X.1
Chelghoum, Y.2
Cannas, G.3
Elhamri, M.4
Labussière, H.5
Tigaud, I.6
|